| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 01/08/2004 | WO2002053130A3 Sustained release drug delivery devices with coated drug cores |
| 01/08/2004 | WO2001079524A3 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 01/08/2004 | US20040006136 Anthelmintics for preventing parasitic infections in human and animals |
| 01/08/2004 | US20040006131 Compounds selectively inhibiting gamma 9 delta 2 T lymphocytes |
| 01/08/2004 | US20040006098 Induce cytokine biosynthesis in animals |
| 01/08/2004 | US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 01/08/2004 | US20040006047 Heterocyclic amides, a process for their preparation, compositions comprising them and their use |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005344 A head lice shampoo contains adhatoda and stemona which together increase the kill rate of lice. The shampoo can be substantially free of pyrtherin. |
| 01/08/2004 | US20040005318 Method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided. |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | DE10227269A1 Thiazolderivate Thiazole derivatives |
| 01/08/2004 | CA2490016A1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/07/2004 | EP1378512A1 Optically pure camptothecin analogues |
| 01/07/2004 | EP1377275A2 Vaccine for modulating between t1 and t2 immune responses |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465364A Ointment for curing brandy nose |
| 01/07/2004 | CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 01/07/2004 | CN1133460C Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroyfatty acid |
| 01/06/2004 | US6673820 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 01/06/2004 | CA2106895C Combating fish parasites |
| 01/02/2004 | EP1374907A2 Drug transport and delivery system |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373368A1 Compounds for a controlled release of active compounds |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373298A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
| 01/02/2004 | EP1373290A1 Pesticidal spinosyn derivatives |
| 01/02/2004 | EP1373249A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1372735A2 Conjugate of hydroxyalkyl starch and an active agent |
| 01/02/2004 | EP1372704A1 Monocyte-specific particulate delivery vehicle |
| 01/02/2004 | EP1372663A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives |
| 01/02/2004 | EP1372659A1 Substances for use in therapy of diseases that are caused by highly proliferative cells |
| 01/02/2004 | EP1372654A2 Quinoline inhibitors of hyak1 and hyak3 kinases |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372622A1 Parasiticidal compositions and methods of use |
| 01/01/2004 | US20040002585 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002103 Synthetic ligation reassembly in directed evolution |
| 01/01/2004 | US20040001867 Vectors for molecule delivery to CD11b expressing cells |
| 12/31/2003 | WO2004000887A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000793A2 Aminoacetonitrile derivatives suitable for controlling parasites |
| 12/31/2003 | WO2004000783A1 Aminoalkylphenols, methods of using and making the same |
| 12/31/2003 | WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 12/31/2003 | WO2004000365A1 Drug transport and delivery system |
| 12/31/2003 | WO2004000352A1 Therapeutic compound against leishmania infection and use thereof |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000306A1 Novel antimalarial agent |
| 12/31/2003 | WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 12/31/2003 | WO2003089577A3 Antihelminthic anthraquinones and method of use thereof |
| 12/31/2003 | WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/31/2003 | WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | CN1132599C Medicine for treating hog cholera |
| 12/31/2003 | CN1132572C Mite-killing face-beauty cream |
| 12/31/2003 | CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 12/31/2003 | CA2490354A1 Drug transport and delivery system |
| 12/31/2003 | CA2489842A1 Aminoacetonitrile derivatives suitable for controlling parasites |
| 12/31/2003 | CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 12/30/2003 | US6670372 Aryl ether substituted imidazoquinolines |
| 12/30/2003 | US6670324 Cyclic peptide antifungal agents |
| 12/30/2003 | US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders |
| 12/30/2003 | US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties |
| 12/30/2003 | US6669947 Stratified and cryogenically stored vaccines, process for their preparation |
| 12/30/2003 | US6669945 Universal T-cell epitopes for anti-malarial vaccines |
| 12/30/2003 | US6669903 Celluose acetate coating for sterilization of Trichophyton (fungi), and enteropathogenic Escherichia coli or methicillin tolerant Staphylococcus aureus |
| 12/30/2003 | CA2163791C Anti-infective materials |
| 12/25/2003 | US20030236389 Proteins, polynucleotides encoding them and methods of using the same |
| 12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 12/24/2003 | WO2003106410A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 12/24/2003 | WO2003105769A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 12/24/2003 | WO2003089593A3 Adjuvant enhanced immunotherapy |
| 12/24/2003 | WO2003066806A3 Therapeutic use of aziridino compounds |
| 12/24/2003 | WO2003028701A3 Liposomes containing (ether)lysolecithins |
| 12/24/2003 | WO2002015897A3 Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections |
| 12/24/2003 | CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament |
| 12/23/2003 | US6667393 Azalide antibiotic compositions |
| 12/23/2003 | US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 12/18/2003 | WO2003104467A1 Means and methods for the production of adenovirus vectors |
| 12/18/2003 | WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors |
| 12/18/2003 | WO2003104205A1 Aryloximes |
| 12/18/2003 | WO2003104204A1 Pyridazine derivatives |
| 12/18/2003 | WO2003104203A1 Therapeutic molecules and methods-1 |
| 12/18/2003 | WO2003104187A1 Amidoacetonitrile compounds and their use as pesticides |
| 12/18/2003 | WO2003103687A1 Liquid formulation of decitabine and use of the same |
| 12/18/2003 | WO2003103636A1 A novel drug dosing regimen |
| 12/18/2003 | WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 12/18/2003 | WO2003103584A2 Ether substituted imidazopyridines |
| 12/18/2003 | WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 12/18/2003 | WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase |
| 12/18/2003 | WO2003057135A3 Aqueous compositions containing metronidazole |
| 12/18/2003 | WO2003045363A3 Treatment of th2 dominated immunological disease states with progesterone receptor antagonists |
| 12/18/2003 | WO2003044021A3 Substituted indolizine-like compounds and methods of use |